Robeco Institutional Asset Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Robeco Institutional Asset Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-33,021	Closed	-$3.82M	–	1146
2023 Q3	$3.82M	Hold	33,021	–	–	0.01%	592
2023 Q2	$3.4M	Hold	33,021	–	–	0.01%	607
2023 Q1	$3.6M	Sell	33,021 -9,301	-22%	-$1.03M	0.01%	612
2022 Q4	$4.82M	Sell	42,322 -7,761	-15%	-$645K	0.01%	575
2022 Q3	$3.1M	Buy	50,083 +3,097	+7%	+$216K	0.01%	589
2022 Q2	$3.75M	Buy	46,986 +40,725	+650%	+$3.86M	0.01%	562
2022 Q1	$660K	Sell	6,261 -28,267	-82%	-$2.75M	﹤0.01%	744
2021 Q4	$3.72M	Buy	34,528 +12,381	+56%	+$1.35M	0.01%	583
2021 Q3	$2.43M	Sell	22,147 -26,051	-54%	-$2.7M	0.01%	640
2021 Q2	$4.51M	Sell	48,198 -747	-2%	-$68.7K	0.01%	592
2021 Q1	$4.51M	Sell	48,945 -5,016	-9%	-$423K	0.01%	572
2020 Q4	$3.95M	Buy	53,961 +50,727	+1,569%	+$3.77M	0.01%	583
2020 Q3	$251K	Buy	+3,234	New	+$223K	﹤0.01%	822
2018 Q4	–	Sell	-10,124	Closed	-$198K	–	1013
2018 Q3	$198K	Sell	10,124 -4,013	-28%	-$76.3K	﹤0.01%	908
2018 Q2	$234K	Buy	+14,137	New	+$216K	﹤0.01%	891

Other funds holding HZNP

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

VWA

Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return

FSWA

Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return

BCMLT

Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Robeco Institutional Asset Management's HZNP Position: Q4 2023 in Review

Robeco Institutional Asset Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 33,021 shares — an estimated $3.82M sold.

Robeco Institutional Asset Management first reported a position in HZNP in Q2 2018 and held it in 15 quarters. The position peaked at $4.82M in Q4 2022. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

Robeco Institutional Asset Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
Robeco Institutional Asset Management sold 33,021 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $3.82M.
Robeco Institutional Asset Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2018 and held it in 15 quarters.
Robeco Institutional Asset Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $4.82M in Q4 2022.
6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Robeco Institutional Asset Management's 13F filing for Q4 2023, filed 8 Feb 2024.